SGCD

At least 14 mutations in the SGCD gene have been identified in people with limb-girdle muscular dystrophy type 2F. Limb-girdle muscular dystrophy is a group of related disorders characterized by muscle weakness and wasting, particularly in the shoulders, hips, and limbs. People with limb-girdle muscle dystrophy type F have SGCD mutations in both copies of the gene in each cell (autosomal recessive inheritance pattern).

A small number of people with limb-girdle muscular dystrophy type 2F have developed a heart condition called dilated cardiomyopathy. Dilated cardiomyopathy is a form of heart disease that enlarges and weakens the heart (cardiac) muscle, preventing it from pumping blood efficiently. Dilated cardiomyopathy progresses rapidly and can be life-threatening.

Forms of limb-girdle muscular dystrophy caused by gene mutations that affect the sarcoglycan complex are called sarcoglycanopathies. SGCD gene mutations may prevent the sarcoglycan complex from forming or from binding to and stabilizing the dystrophin complex. Problems with these complexes reduce the strength and resilience of muscle fibers and result in the signs and symptoms of limb-girdle muscular dystrophy.

MedlinePlus Genetics provides information about Familial dilated cardiomyopathy

A small number of people who develop dilated cardiomyopathy without skeletal muscle involvement have been found to have a mutation in one copy of the SGCD gene in each cell, an inheritance pattern called autosomal dominant.

Since other individuals with one SGCD gene mutation in each cell have normal heart muscle, some researchers question whether SGCD gene mutations are related to autosomal dominant dilated cardiomyopathy.